U.S. Markets open in 13 mins

Is Bristol-Myers Squibb (BMY) a Great Dividend Play?

Zacks Equity Research
Asbury Automotive (ABG) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

All investors love getting big returns from their portfolio, whether it's through stocks, bonds, ETFs, or other types of securities. However, when you're an income investor, your primary focus is generating consistent cash flow from each of your liquid investments.

While cash flow can come from bond interest or interest from other types of investments, income investors hone in on dividends. A dividend is that coveted distribution of a company's earnings paid out to shareholders, and investors often view it by its dividend yield, a metric that measures the dividend as a percent of the current stock price. Many academic studies show that dividends make up large portions of long-term returns, and in many cases, dividend contributions surpass one-third of total returns.

Bristol-Myers Squibb in Focus

Based in New York, Bristol-Myers Squibb (BMY) is in the Medical sector, and so far this year, shares have seen a price change of 0.33%. Currently paying a dividend of $0.4 per share, the company has a dividend yield of 2.6%. In comparison, the Large Cap Pharmaceuticals industry's yield is 2.68%, while the S&P 500's yield is 1.81%.

Looking at dividend growth, the company's current annualized dividend of $1.60 is up 2.6% from last year. Bristol-Myers Squibb has increased its dividend 5 times on a year-over-year basis over the last 5 years for an average annual increase of 2.54%. Looking ahead, future dividend growth will be dependent on earnings growth and payout ratio, which is the proportion of a company's annual earnings per share that it pays out as a dividend. Bristol-Myers's current payout ratio is 47%. This means it paid out 47% of its trailing 12-month EPS as dividend.

Earnings growth looks solid for BMY for this fiscal year. The Zacks Consensus Estimate for 2018 is $3.62 per share, representing a year-over-year earnings growth rate of 20.27%.

Bottom Line

Investors like dividends for many reasons; they greatly improve stock investing profits, decrease overall portfolio risk, and carry tax advantages, among others. But, not every company offers a quarterly payout.

For instance, it's a rare occurrence when a tech start-up or big growth business offers their shareholders a dividend. It's more common to see larger companies with more established profits give out dividends. Income investors must be conscious of the fact that high-yielding stocks tend to struggle during periods of rising interest rates. That said, they can take comfort from the fact that BMY is not only an attractive dividend play, but also represents a compelling investment opportunity with a Zacks Rank of #2 (Buy).


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Bristol-Myers Squibb Company (BMY) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.